Experiences of discrimination are associated with increased distress and lead to both diminished quality of life and a decrease in resources needed to successfully sustain recovery.
TMS and Other Brain Stimulation Therapies
Joan Camprodon, MD, PhD, MPH
Novel Combination and Augmentation Strategies in Depression
Maurizio Fava, MD
The Role of Placebo in Clinical Practice
Cristina Cusin, MD
Biological Targeting and Antidepressants
David Mischoulon, MD, PhD
Acceptance and Commitment Therapy
John D. Matthews, MD
- Staff Story
- Nov | 1 | 2019
The Department of Psychiatry welcomed Maurizio Fava, MD, as the new leader of the department on October 1. Dr. Fava reflects on his outlook as he takes over as chair of the department.
- Press Release
- Oct | 15 | 2019
A team led by Massachusetts General Hospital researchers report that mindfulness meditation appears to help extinguish fearful associations.
- Sep | 30 | 2019
Mass General Clinicians and Researchers Brainstorm Ways to Treat and Prevent Nervous System Disorders
Experts from Neurology, Neurosurgery, Psychiatry and beyond gathered at the Bulfinch tents to attend the hospital’s second annual Neuroscience Day, created to foster collaboration among researchers and physicians from one of the world’s largest neuroscience communities.
- Aug | 23 | 2019
Heading back to school is often filled with anxiety for both parents and kids. Ellen Braaten, PhD, co-director of The MGH Clay Center for Young Healthy Minds, shares tips to help prepare.
- Aug | 23 | 2019
The MGH Department of Psychiatry will welcome a new leader Oct. 1. With more than 25 years of academic and clinical experience in psychiatry, Maurizio Fava, MD, has been named the department’s new psychiatrist-in-chief.